Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. - Wikidata - wikimedia - TriplyDB

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

http://www.wikidata.org/entity/Q35696355

about

Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model Glioblastoma cancer stem cells: Biomarker and therapeutic advances In vivo models of primary brain tumors: pitfalls and perspectives.Single-molecule decoding of combinatorially modified nucleosomes Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.Current status of gene therapy for brain tumors.Brain tumor cells in circulation are enriched for mesenchymal gene expression Insulator dysfunction and oncogene activation in IDH mutant gliomas.Comparative analysis of methods for identifying recurrent copy number alterations in cancer.Riparian ecosystems in human cancers.In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.Emerging insights into the molecular and cellular basis of glioblastoma.Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.Biological and clinical implications of cancer stem cells in primary brain tumors.Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200 Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

P2860

Q21133610-802E823A-1B49-40F5-9DA9-2027D79B55A1 Q26859782-8FA09026-3769-461C-B1F2-3E11674DE258 Q26862847-0C0A6141-3B2A-4C44-B5C3-5CEA54150F1B Q28830526-5D09737E-25CA-4F48-9E94-2D62E3028507 Q29615604-9B00EB46-632A-43D6-AAD7-7144ECC26A2B Q30834482-FA2038C1-1169-497C-9E34-EB9C60238B97 Q33572502-2368DDE9-62BF-44C0-88E1-8E04527FA425 Q33677057-713FC185-1DAF-4F68-9656-831AA06D3319 Q33804713-09DAADDB-BD96-4306-877F-C5BAB3BD8346 Q34047392-54AB97FA-E5D8-49F2-BDD5-CD5BA4962DEC Q34102273-C812B8EE-FD3D-414B-AF23-064FE9D3405D Q34318157-70871DB8-5009-48DB-B9C3-AA89DFEDF4F4 Q34458631-8FF2C4C6-0425-498A-99F7-6C351DEC8524 Q34506441-589F76DF-0185-4DBF-98AE-E6D60DF112BA Q34534035-F732C129-94BA-4EA5-8431-803CA467562B Q34581896-0ADFFA3F-A14C-4BDF-BC0C-BAD20078634E Q35545752-90CEBFF8-D59F-4A02-9C8C-021C824F6081 Q35648484-7F8DFD26-1ACF-40E9-91D4-C76687E1983C Q35679830-981A7554-AF80-404E-8E10-E425AB287E19 Q35759208-00CC3F16-FEF1-4CFC-A399-512AA736A776 Q35794896-B52C4E4B-DEDB-4F33-9F2C-090EE5C5BB24 Q35867997-77305609-5B9B-49CA-B63D-0088746CB2F5 Q35914897-E1849B57-2129-4E5F-92CB-6CFF014D3939 Q35974087-76F1FFDB-AC3A-4053-AAFC-4134BE616688 Q36062158-FA7A6D8B-B290-4190-BFC5-95FA63F03744 Q36145048-3DB9E115-97BF-4F71-B28A-679E01658A96 Q36213711-81674A71-0E2A-447F-B8E0-7F75E0D52B14 Q36347256-9344247D-745C-4B98-BC24-F9FF345E386E Q36562573-A6C0999A-3EA2-4B66-A803-F51F6D2CB6B6 Q36575238-04A60C94-A6DF-4364-A180-C4A1411EB6BC Q36618220-2778A6D6-B333-4334-9C91-3D8C24BED176 Q36636067-2DAA7479-6232-44EF-B311-1583CA8721CF Q36756817-763AE284-2BEC-4204-8DDC-1CC717486358 Q36866011-33D7D773-F79E-402D-9EA8-1BBB79B14167 Q36879211-29F3DB33-A0F4-4F23-9CC6-D2BB568A08E1 Q36917721-3498EE23-8521-41FE-98AD-6528448C1B7B Q36947035-334B0469-E507-456A-AA54-97F68C100068 Q37126620-BBD41CEA-1CFC-4114-BA53-716513C6833E Q37230411-89A01DFF-2A22-4D51-B839-EB3C402FD8B3 Q37660295-469D2568-4B58-4439-BF4C-496AFF70D0DD

P2860

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

http://www.wikidata.org/entity/Q35696355

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

@ast

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

@en

type

label

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

@ast

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

@en

prefLabel

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

@ast

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

@en

P1433

Q35696355-B63B33DC-175A-4456-B868-FC4158D5EC8F

P1476

Q35696355-A495D0EA-6EA4-4451-9660-3D645772B21E

P2093

Q35696355-62C2001D-A83B-475B-97B9-3F09E9B8B309

Q35696355-7C50074B-2236-4D0C-B734-73E3820959B6

Q35696355-90C0BFD8-DBDE-4992-9469-A8AC0FB217E4

Q35696355-9EF81AE1-C689-47B9-95E2-81844923FD05

Q35696355-AB763FF2-3B37-4C8C-9684-2643266375BF

Q35696355-BD166801-4ACB-4140-8944-5F727F06CFD1

Q35696355-BEF6CF9C-2AB8-4B28-A8E0-F0F934D33728

Q35696355-C8EC5067-3C09-4F1D-A355-0A43B3B31083

Q35696355-D29C9FF3-FB8C-4FEA-862A-4D9A904BC22D

Q35696355-E1D40BB2-F802-468A-86E4-5DFC7D2758E5

P2860

Q35696355-0B1AE7FC-F44F-4F64-B7AE-4C66B64D76E3

Q35696355-0DE08D85-C6BE-4B31-8071-8B5ECEAD4C3F

Q35696355-18613759-020C-478A-A682-36051DF76C25

Q35696355-1CBE1D4B-E77F-4524-B781-0E2C8031DE89

Q35696355-26369AA0-7D98-4D83-A609-C0FB1C015107

Q35696355-3AEFEB2E-240F-4097-B8D1-7E09F715D345

Q35696355-3B95C728-FC25-4892-8B01-03F29B3A3F95

Q35696355-3C2CBD4E-07EF-4073-BBA4-29A28DF25CB5

Q35696355-4207ED26-5557-4C8E-9EB8-3505B1CEEF08

Q35696355-45F67253-9DF2-4692-A67C-421A3F839D22

P304

Q35696355-D85368E5-5E51-4C32-8849-D9B16E1782E6

P31

Q35696355-6701C7A5-DF8A-45F1-B86A-92499C833E22

P356

Q35696355-AE8C9768-A1D0-44E3-9BA0-1DB4571C477A

P433

Q35696355-2AAE920D-3F3A-4FF5-8A3A-1C6D6F2F17AC

P478

Q35696355-CA3D9C68-932D-481D-BBC3-8EE1FDAE59A3

P50

Q35696355-3BB6670B-06AE-4B6F-88A0-70899CF78D86

Q35696355-54C8F98F-CDA0-43AC-AF7B-02AE3957D230

P577

Q35696355-8AEB42B5-C28A-4404-848A-29C40A7C13B5

P5875

Q35696355-0D17021A-6DA8-44F4-A1EA-CDB94FEF756A

P698

Q35696355-0F953678-D67E-4B03-AF00-7E9FC185C532

P932

Q35696355-DB74E9DB-B99F-40A8-83FD-E5B16F5C689E

P356

P1433

P1476

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

@en

P2093

Anat O Stemmer-Rachamimov

http://www.w3.org/2001/XMLSchema#string

Anoop P Patel

http://www.w3.org/2001/XMLSchema#string

David N Louis

http://www.w3.org/2001/XMLSchema#string

Gayatry Mohapatra

http://www.w3.org/2001/XMLSchema#string

Hiroaki Wakimoto

http://www.w3.org/2001/XMLSchema#string

Mai Nitta

http://www.w3.org/2001/XMLSchema#string

Ryuichi Kanai

http://www.w3.org/2001/XMLSchema#string

Stephen Yip

http://www.w3.org/2001/XMLSchema#string

William T Curry

http://www.w3.org/2001/XMLSchema#string

Zachary R Barnard

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Stem cells, cancer, and cancer stem cells

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of human brain tumour initiating cells

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

Modeling the initiation and progression of human acute leukemia in mice

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

P304

132-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOR195

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Samuel D Rabkin

Robert L Martuza

P577

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51783530

http://www.w3.org/2001/XMLSchema#string

P698

22067563

http://www.w3.org/2001/XMLSchema#string

P932

3266381

http://www.w3.org/2001/XMLSchema#string